Medline Inc.
MDLN · Nasdaq
- $32.53
- $42.85B
- Open
- —
- —
- $32.12 - $32.86
- $31.87 - $50.88
- —
- —
- 4.65M
About Medline Inc.
Medline operates a healthcare-products business, selling medical supplies and related products to healthcare customers. The supplied evidence does not identify its operating segments, disclose the contribution of each segment, or specify its customer mix beyond the company’s healthcare orientation. Its reported FY2025 revenue was $28.4 billion, establishing substantial operating scale, while reported net income was approximately $1.2 billion in one disclosure. The financial data also contains a contradictory line showing $1,157.0 billion of net income and NaNB revenue, so the supplied figures do not support a reliable segment or profitability breakdown beyond the $28.4 billion revenue figure.
Notable Price Movement
- Aug 3-7$35.2310.31%
Medline rose $1.53, or 3.78%, from $40.51 to $42.04 over the reported week. The stock first weakened, falling to $39.12 by July 30 before stabilizing at $39.28 on July 31. It then reversed higher, gaining to $40.47 on August 3 and $42.04 on August 4, with volume increasing to 7.73 million shares on the final session from 5.25 million the day before. The supplied evidence contains no company-specific announcement or financial release explaining the rebound, and it provides no broader market or sector catalyst. Accordingly, the week appears to reflect trading without identified company-specific news rather than a clearly documented fundamental trigger.
